Superfluid Dx
San Diego
About Superfluid Dx
Tissue-specific cell-free circulating RNA is a newly developed area for molecular diagnosis. Based on this powerful non-invasive approach, Molecular Stethoscope aims to transform healthcare by providing early insight into a patient’s healthy versus disease state.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $8.2M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2023)
- Website: molecularstethoscope.com
- Phone: (858)500-8500
Industries & Categories
Biotechnology, Health Care, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/superfluid-dx-11121 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.